Connection

Patrick O'Neil to Risk Reduction Behavior

Back to Details
This is a "connection" page, showing publications Patrick O'Neil has written about Risk Reduction Behavior.
Patrick O'Neil
Connection Strength
0.091
Risk Reduction Behavior
  1. Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study. Obesity (Silver Spring). 2012 Jul; 20(7):1426-36.
    View in: PubMed
    Score: 0.091
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.